COMPANY
Genomenon
Our Clinical Services team provides accurate, up-to-date variant analysis, leveraging the latest genomic and disease literature to support accurate and confident clinical decisions. From company website Source · Oct 13, 2026
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Revenue Operations Analyst (Bosnia and Herzegovina) | Bosnia and Herzegovina | Sep 9, 2026 | Oct 5, 2026 |
| General Interest in Genomenon for B&H: Share your resume and we'll keep it on file! | Sarajevo/Tuzla Office, B&H | Nov 27, 2025 | Oct 5, 2026 |
| General Interest in Genomenon: Share your resume and we'll keep it on file! | Remote, USA | Oct 24, 2024 | Oct 5, 2026 |
Funding and NIH signals
- SEC Form D raise Raised $6.03M (Form D filed Jul 30, 2026); 3 roles open. SEC Form D 0001650557-26-000004 (Jul 30, 2026)
Evidence (1 event)
- Jul 30, 2026 · SEC Form D 0001650557-26-000004
Name of Issuer: Genomenon, Inc.; CIK: 1650557; Address: Ann Arbor, MI; Submission type: D; Filing date: 2026-07-30; Industry Group: Biotechnology; Date of First Sale: 2026-07-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 6025002; Federal exemptions: 06b
- Jul 30, 2026 · SEC Form D 0001650557-26-000004
Timeline
- Board tracked Radar started tracking this company’s job board (3 open jobs at last check). source ↗
Open jobs 3
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Revenue Operations Analyst (Bosnia and Herzegovina) | Bosnia and Herzegovina | Sep 9, 2026 | Oct 5, 2026 | Mid |
| General Interest in Genomenon for B&H: Share your resume and we'll keep it on file! | Sarajevo/Tuzla Office, B&H | Nov 27, 2025 | Oct 5, 2026 | Not stated |
| General Interest in Genomenon: Share your resume and we'll keep it on file! | Remote, USA | Oct 24, 2024 | Oct 5, 2026 | Not stated |
NIH awards 6
- NIH award 5R44HG010446-03 FY2022: $855,024 awarded for that fiscal year; activity R44 (SBIR); PI KIEL, MARK JULIN; recipient as written: GENOMENON, INC., Ann Arbor, MI. Micropublications for Automating Genome Sequenc source ↗
- NIH award 2R44HG010446-02 FY2021: $855,024 awarded for that fiscal year; activity R44 (SBIR); PI KIEL, MARK JULIN; recipient as written: GENOMENON, INC., Ann Arbor, MI. Micropublications for Automating Genome Sequenc source ↗
- NIH award 1R43HG010446-01A1 FY2019: $152,946 awarded for that fiscal year; activity R43 (SBIR); PI KIEL, MARK JULIN; recipient as written: GENOMENON, INC., Ann Arbor, MI. Micropublications for Automating Genome Seque source ↗
- NIH award 5R44HG009474-03 FY2019: $737,032 awarded for that fiscal year; activity R44 (SBIR); PI KIEL, MARK JULIN; recipient as written: GENOMENON, INC., Ann Arbor, MI. Commercial Software Using High-throughput Compu source ↗
- NIH award 4R44HG009474-02 FY2018: $747,666 awarded for that fiscal year; activity R44 (SBIR); PI KIEL, MARK JULIN; recipient as written: GENOMENON, INC., Ann Arbor, MI. Commercial Software Using High-throughput Compu source ↗
- NIH award 1R44HG009474-01 FY2017: $224,417 awarded for that fiscal year; activity R44 (SBIR); PI KIEL, MARK JULIN; recipient as written: GENOMENON, INC., Ann Arbor, MI. Commercial Software Using High-throughput Compu source ↗
Connect
See your connections at Genomenon on LinkedIn (search by name, results not checked)